This heterogeneity is associated with the expression of different immunohistochemical markers and categorized into four main molecular subtypes of BC tumors: luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, and basal-like also known as triple-negative (TNBC). The gene discussed is ERBB2; the disease is breast cancer.